Comment Re:unsportsmanlike buttock comfort (Score 1) 117
Come to think of it, I'm basically agreeing with you... but I think it's good.
Come to think of it, I'm basically agreeing with you... but I think it's good.
But would I ever push the button secure in the knowledge that I am invulnerable - can't imagine it. Imagine if missile defense worked really well and only 15% of the US population were wiped out and the radiation over the rest of the country were "usually" survivable. It's unimaginable.
Condolences in advance to the families of the developers who take that offer due to their unfortunate suicide in a month or two
This is "insightful"? Good lord. Maybe wait until there's some shadow of evidence to your conspiracy theory?
I thought you were going to say they would be offered stock options etc. that probably wouldn't actually amount to that much because AI is crap. I don't universally agree with that either, but it's not ridiculous.
What I do think is likely is that Sam Altman is exaggerating.
What makes this one so funny is they respond SO guiltily. It's hilarious. But I don't need some over-reaching attempt to wordplay it into being a big new social issue.
It does seem like Trump is turning a corner now. But many lives have already been lost and it's confusing and threatening that Trump has acted this way.
As for individual solar systems, according to what I just looked up, stars fizzle out and become either a white dwarf, or (for massive stars) a neutron star or black hole - but not again a star in any case.
In contrast the "big beautiful bill" that did pass didn't cut cancer funding. (It did include the Orphan Cures Act, which cuts regulation and eases reimbursement for some diseases including cancer, but doesn't directly increase funding for them).
So, it's premature to declare drastic cancer cuts as a done deal, although it's a big threat, although it's not "zeroing out" federal funding.
Also how much of cancer research is funding by the federal govt vs private industry I'm not sure - but private research certainly won't be discontinued, since it's profitable. One of the cancer medicines I'm on is $23,000 per little IV baggie. Not sure how much of that goes straight into dividends and buybacks vs research.
Do you suffer painful elimination? -- Don Knuth, "Structured Programming with Gotos"